Foundation to Eradicate Duchenne Report issue

Foundation Phase 2

Organization Overview

First Clinical Trial
2019
NCT03936894
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Foundation to Eradicate Duchenne